SOMERSET, N.J., Sept. 5, 2025 /PRNewswire/ — With prostate cancer affecting one in eight men, ProCure Proton Therapy Center is calling on news media to help educate the public about the benefits of proton therapy, a powerful and precise treatment often misunderstood by patients and physicians alike.
“My colleagues and I are confident that with our expertise and the help of responsible journalists, we can set the record straight on why more prostate cancer patients should consider proton therapy,” said Medical Director Brian Chon, M.D.
Proton therapy precisely targets cancer cells while sparing healthy tissue. Compared to conventional radiation therapy, proton therapy reduces unnecessary radiation to the bladder and bowels by 60–70%. More precision with proton therapy can mean fewer side effects.
While some mistakenly believe proton therapy is an “experimental treatment,” it has been an FDA-approved clinical technology since 1988. Peer-reviewed studies, such as one by Smith and colleagues in the International Journal of Radiation, Oncology, Biology, Physics, have demonstrated high cancer survival rates and low incidence of side effects.
Proton therapy is also more accessible than commonly perceived. ProCure’s center in Somerset, NJ, is easy-to-reach for residents in the New York and Philadelphia metropolitan areas and beyond. The treatment is also covered by more insurers than many realize, and ProCure is dedicated to helping patients navigate the financial aspects of their care.
Dr. Chon and his colleagues on ProCure’s physician team are available to journalists to provide further education on this vital topic.
About ProCure Proton Therapy CenterProCure Proton Therapy Center in Somerset, NJ, opened in March 2012 as the tri-state region’s first proton therapy facility, treating a range of cancers including diseases of the prostate, breast, lung, brain, head and neck, and gastrointestinal system, as well as sarcomas and many pediatric cases. Using the most advanced radiation treatment available, ProCure has treated more than 7,400 patients overall, including 750+ pediatric patients coming from the U.S. and abroad, and enables many cancer patients to choose a non-surgical treatment personalized to their medical needs and lifestyles, often with fewer side effects and less downtime—giving them more freedom to enjoy what matters most in their lives. For more information, visit ProCure.com.
Media Contact:Sarah Ferrington, Marketing Manager
Phone: 732-357-2609
Email: [email protected]
SOURCE ProCure Proton Therapy Center
